Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Opty---transaction history

The 02/23/2010 OA date signifies that TPL didn't use their option of submitting a statement by 01/14/2010 regarding the determination to grant the reex on 11/14/2009. The "Date forwarded to examiner" was due approx. 6 weeks after TPL's optional right to respond expired. See Flow Chart

http://www.uspto.gov/web/offices/pac/mpep/documents/2200_2201.htm

GLTAL

Share
New Message
Please login to post a reply